Major cardiovascular events in long-term multiple myeloma survivors: A Korean case- control study (The CAREMM-2105 study)
Abstract Purpose : Despite improvements in multiple myeloma (MM) survival rates, data on cardiovascular outcomes in long-term survivors remain lacking. Methods : This retrospective case-control study utilized the Korean National Health Insurance Service database (2009–2020) to compare the incidence of cardiovascular disease (CVD) between patients with MM and a matched control group, focusing on long-term (>5 years) survivors. A preliminary case cohort (n=15,402 patients with MM) and a matched control cohort (n=123,216 patients without MM) were established based on birth year and sex. Following 1:1 propensity score matching, the final matched cohorts each comprised 15,402 participants. Results : The case and control cohorts were comparable in mean age (66.2±11.5 years vs. 66.1±11.3 years), sex, age distribution, and comorbidities. By the 8-year follow-up, the cumulative incidence of CV events (12.5% vs. 22.1%) and CVD risk were significantly lower in the case cohort. The 5-year landmark analysis revealed significant differences in CVD incidence between the cohorts (7.8% [case cohort] vs. 9.8% [control cohort]), with variations across age groups and sex, highlighting a significantly higher CVD risk among patients aged <50 years in the case cohort (P<0.001). Conclusions : These findings underscore the need for vigilant CVD monitoring in MM long-term survivors, particularly those aged <50 years at first diagnosis. Implication for Cancer Survivors : This study highlights the importance of integrating cardiovascular monitoring and risk management into long-term care for MM survivors, with a focus on younger patients and personalized interventions..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
ResearchSquare.com - (2024) vom: 04. Apr. Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ha, Jeonghoon [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
---|
doi: |
10.21203/rs.3.rs-4191924/v1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XRA043173799 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | XRA043173799 | ||
003 | DE-627 | ||
005 | 20240405131256.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240405s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21203/rs.3.rs-4191924/v1 |2 doi | |
035 | |a (DE-627)XRA043173799 | ||
035 | |a (ResearchSquare)10.21203/rs.3.rs-4191924/v1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ha, Jeonghoon |e verfasserin |4 aut | |
245 | 1 | 0 | |a Major cardiovascular events in long-term multiple myeloma survivors: A Korean case- control study (The CAREMM-2105 study) |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Purpose : Despite improvements in multiple myeloma (MM) survival rates, data on cardiovascular outcomes in long-term survivors remain lacking. Methods : This retrospective case-control study utilized the Korean National Health Insurance Service database (2009–2020) to compare the incidence of cardiovascular disease (CVD) between patients with MM and a matched control group, focusing on long-term (>5 years) survivors. A preliminary case cohort (n=15,402 patients with MM) and a matched control cohort (n=123,216 patients without MM) were established based on birth year and sex. Following 1:1 propensity score matching, the final matched cohorts each comprised 15,402 participants. Results : The case and control cohorts were comparable in mean age (66.2±11.5 years vs. 66.1±11.3 years), sex, age distribution, and comorbidities. By the 8-year follow-up, the cumulative incidence of CV events (12.5% vs. 22.1%) and CVD risk were significantly lower in the case cohort. The 5-year landmark analysis revealed significant differences in CVD incidence between the cohorts (7.8% [case cohort] vs. 9.8% [control cohort]), with variations across age groups and sex, highlighting a significantly higher CVD risk among patients aged <50 years in the case cohort (P<0.001). Conclusions : These findings underscore the need for vigilant CVD monitoring in MM long-term survivors, particularly those aged <50 years at first diagnosis. Implication for Cancer Survivors : This study highlights the importance of integrating cardiovascular monitoring and risk management into long-term care for MM survivors, with a focus on younger patients and personalized interventions. | ||
650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
700 | 1 | |a Choi, Suein |e verfasserin |4 aut | |
700 | 1 | |a Moon, Seulji |e verfasserin |4 aut | |
700 | 1 | |a Han, Jinseon |e verfasserin |4 aut | |
700 | 1 | |a Lee, Jeongyoon |e verfasserin |4 aut | |
700 | 1 | |a Baek, Ki-Hyun |e verfasserin |4 aut | |
700 | 1 | |a Han, Seunghoon |e verfasserin |4 aut | |
700 | 1 | |a Park, Sung-Soo |e verfasserin |4 aut | |
700 | 1 | |a Min, Chang-Ki |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2024) vom: 04. Apr. |
773 | 1 | 8 | |g year:2024 |g day:04 |g month:04 |
856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-4191924/v1 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
912 | |a GBV_XRA | ||
951 | |a AR | ||
952 | |j 2024 |b 04 |c 04 |